Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DEP114 vs Desloratadine in Pediatric Persistent Allergic Rhinitis
NCT06272409Phase 3Not yet recruiting
- Sponsor
- EMS
- Start
- Feb 2025
- Primary completion
- Mar 2025
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of DEP114 in allergic rhinitis (AR), sponsored by EMS. Planned start Feb 2025; status: not yet recruiting.
02
Drugs
DEP114
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on NCT06272409.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06272409.